according to jsonline
FluGen begins clinical trial on universal influenza vaccine
FluGen begins clinical trial on universal influenza vaccine
By of theFluGen Inc., a Madison biotechnology company that is developing flu vaccines, said Wednesday it has begun a clinical trial of its RedeeFlu universal influenza vaccine.The trial involves 96 healthy adult subjects between the ages of 18 and 49.It will evaluate the safety of the vaccine and the antibody and T-cell responses it prompts.
not to mention pharmacist
Effectiveness of the influenza vaccine in preventing hospitalization and death in type 2 diabetics
Effectiveness of the influenza vaccine in preventing hospitalization and death in type 2 diabetics
In addition to its intended purpose, U.K. researchers say influenza vaccination is an important protective measure against cardiovascular (CDV) events in people with type 2 diabetes.The retrospective study included an estimated 124,500 patients with the condition, divided into cohorts according to whether or not they had been vaccinated against influenza.Hospitalizations for acute myocardial infarction, stroke, heart failure, or pneumonia/influenza were tracked in the two sets of participants for a period of 7 years, as were all-cause deaths.
let alone madison
FluGen starts tests of a new influenza vaccine on humans
FluGen starts tests of a new influenza vaccine on humans
Close Get email notifications on Judy Newman | Wisconsin State Journal daily!Your notification has been saved.There was a problem saving your notification.
No comments:
Post a Comment